Drug product formulations exert a crucial role in determining the degree of drug bioavailability. Bioavailability refers to the fraction of an administered dose that enters the systemic circulation in an active form. Optimizing formulations can significantly boost this process, leading to more ef

Peptide companies in the United States have witnessed unprecedented growth, with the FDA approving a record number of peptide-based therapeutics in recent years. Indeed, these specialized molecules now account for over 5% of all approved drugs, underscoring their growing importance in modern medi